title: In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs.
abstract: Pulmonary alveolar surfactant can be separated into different subtypes on the basis of their buoyant densities. These subtypes have been characterized as ultraheavy and heavy forms, which are surface-active, and light forms, which are less surface active. The ratio of these subtypes was altered in an animal model of acute lung injury that contributed to the physiologic abnormalities. We used an in vitro method of surface-area cycling to compare conversion of heavy subtypes isolated from injured and from normal lungs. Lung injury was induced in adult rabbits with a subcutaneous injection of N-nitroso-N-methylurethane (NNMU). Conversion of NNMU-injured heavy subtypes to light subtypes was significantly greater than normal heavy subtype conversion at each time point studied from 60 to 180 min of cycling (p less than 0.01). Surfactant protein A (SP-A) was added to heavy subtypes, with no effect on conversion when 1.5% SP-A was added, but the addition of 4.5, 10.5, and 22.5% caused complete conversion to ultraheavy forms with no cycling. With subsequent cycling, there was greater conversion from ultraheavy to lighter subtypes for normal surfactant material than for NNMU-injured material (p less than 0.05). We conclude that the altered ratio of surfactant subtypes in the alveolar lavage of injured lungs was due to a greater conversion of these subtypes within the alveolar space. Furthermore, SP-A may play an important role in the metabolism of alveolar surfactant both in normal and in injured lungs.
authors.affiliation: Department of Pediatrics, Harbor-UCLA Medical Center, Torrance 90509.
authors.forename: R
authors.initials: R
authors.lastname: Higuchi
authors.forename: J
authors.initials: J
authors.lastname: Lewis
authors.forename: M
authors.initials: M
authors.lastname: Ikegami
mesh_terms: D000818:Animals; D001992:Bronchoalveolar Lavage Fluid; D002499:Centrifugation, Density Gradient; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D009605:Nitrosomethylurethane; D011663:Pulmonary Surfactants / Q000145:classification / Q000302:isolation & purification / Q000378:metabolism*; D011817:Rabbits
chemical_list: D011663:Pulmonary Surfactants; D009605:Nitrosomethylurethane